BTAI icon

BioXcel Therapeutics

93 hedge funds and large institutions have $283M invested in BioXcel Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 25 closing their positions.

Holders
93
Holders Change
-11
Holders Change %
-10.58%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
38
Reduced
23
Closed
25
Calls
$4.8M
Puts
$2.88M
Net Calls
+$1.92M
Net Calls Change
+$2.22M
Name Market Value Shares Shares
Change
Shares
Change %
SFI
101
Susquehanna Fundamental Investments
Pennsylvania
-10,076 Closed
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-9,646 Closed
Squarepoint
103
Squarepoint
New York
-9,438 Closed
RJA
104
Raymond James & Associates
Florida
-8,127 Closed
JF
105
Jump Financial
Illinois
-7,967 Closed
Invesco
106
Invesco
Georgia
-7,407 Closed
Cambridge Investment Research Advisors
107
Cambridge Investment Research Advisors
Iowa
-7,350 Closed
SG Americas Securities
108
SG Americas Securities
New York
-6,822 Closed
PHK
109
Point72 Hong Kong
Hong Kong
-3,589 Closed
LC
110
Lindbrook Capital
California
-2,000 Closed
GEA
111
Glen Eagle Advisors
New Jersey
-330 Closed
WT
112
Washington Trust
Rhode Island
-250 Closed
CAPTRUST Financial Advisors
113
CAPTRUST Financial Advisors
North Carolina
$0 17 -250 -94%
JCM
114
Jacobi Capital Management
Pennsylvania
-150 Closed
TCWM
115
Total Clarity Wealth Management
Illinois
-125 Closed
AIM
116
Anchor Investment Management
South Carolina
-34 Closed
HI
117
Harbour Investments
Wisconsin
-3 -100%
HT
118
HAP Trading
New York
PFA
119
Paradigm Financial Advisors
Missouri
CFGS
120
Concourse Financial Group Securities
Alabama
DFCM
121
Dark Forest Capital Management
Puerto Rico
$0 24 +24 New